BSX vs HRMY · P/E 20, rev $10.65B vs P/E 14, rev $476.7M
Boston Scientific Corp (BSX) versus Harmony Biosciences Holdings (HRMY) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Harmony Biosciences Holdings (HRMY) is a biotechnology company listed on NASDAQ.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported HRMY revenue for 2026-06-30 was $476.7M. Net income was $107.9M. HRMY currently screens at market cap $1.96B and trailing P/E 13.6.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. HRMY currently screens at market cap $1.96B and trailing P/E 13.6.
Not investment advice. Open the BSX and HRMY stock pages for the full models.
Not investment advice.